- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Russia's economic crisis has created unique investment opportunities. Here are two traded in the U.S. that have yields above 11%.
Samsung is starting to share its $77 billion cash hoard with investors. When Apple started increasing its dividends, the stock shot up. Will the same happen for Samsung?
Here are ten stocks that pay solid dividends that are undervalued right now.
There is a select group of dividend stocks that have increased their dividends each year for 25 or more consecutive years called the Dividend Aristocrats.
Procter & Gamble is one of Warren Buffett's largest holdings. Find out why it was his least-attractive dividend aristocrat holding and ripe to sell.
The marijuana market in the U.S. could generate revenue of about $40 billion per year. Find out how Altria's stake could be worth $25 billion now.
It is very difficult to find high-quality businesses trading at cheap prices in the stock market today. Insurers Aflac and Chubb are two such businesses.
Both are trimming operations. Which company's plans will better reward shareholders?
Emerging market pharmaceutical sales are exploding. Find out if Abbott Laboratories or Johnson & Johnson is best positioned to take advantage of the booming emerging market pharmaceutical market.
Find out how these stocks measure up against each other and the surprising direction the oil industry is headed.